Neogen Past Earnings Performance
Past criteria checks 1/6
Neogen's earnings have been declining at an average annual rate of -37.7%, while the Medical Equipment industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 18.8% per year. Neogen's return on equity is 0.05%, and it has net margins of 0.2%.
Key information
-37.7%
Earnings growth rate
-37.9%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 18.8% |
| Return on equity | 0.05% |
| Net Margin | 0.2% |
| Last Earnings Update | 29 Feb 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Neogen makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 29 Feb 24 | 929 | 2 | 322 | 24 |
| 30 Nov 23 | 919 | 12 | 354 | 27 |
| 31 Aug 23 | 919 | -27 | 336 | 28 |
| 31 May 23 | 822 | -23 | 284 | 26 |
| 28 Feb 23 | 721 | -13 | 267 | 23 |
| 30 Nov 22 | 631 | -16 | 185 | 20 |
| 31 Aug 22 | 531 | 36 | 145 | 18 |
| 31 May 22 | 527 | 48 | 142 | 17 |
| 28 Feb 22 | 514 | 49 | 154 | 17 |
| 30 Nov 21 | 503 | 57 | 133 | 17 |
| 31 Aug 21 | 487 | 62 | 128 | 17 |
| 31 May 21 | 468 | 61 | 122 | 16 |
| 28 Feb 21 | 450 | 61 | 120 | 16 |
| 30 Nov 20 | 433 | 60 | 114 | 15 |
| 31 Aug 20 | 426 | 61 | 113 | 15 |
| 31 May 20 | 418 | 59 | 114 | 15 |
| 29 Feb 20 | 419 | 59 | 114 | 15 |
| 30 Nov 19 | 417 | 60 | 112 | 14 |
| 31 Aug 19 | 416 | 60 | 112 | 14 |
| 31 May 19 | 414 | 60 | 111 | 13 |
| 28 Feb 19 | 413 | 62 | 109 | 11 |
| 30 Nov 18 | 410 | 65 | 109 | 11 |
| 31 Aug 18 | 403 | 66 | 107 | 11 |
| 31 May 18 | 398 | 63 | 105 | 11 |
| 28 Feb 18 | 389 | 58 | 104 | 11 |
| 30 Nov 17 | 382 | 52 | 102 | 11 |
| 31 Aug 17 | 372 | 46 | 99 | 11 |
| 31 May 17 | 358 | 44 | 94 | 10 |
| 28 Feb 17 | 353 | 41 | 95 | 10 |
| 30 Nov 16 | 341 | 39 | 93 | 10 |
| 31 Aug 16 | 330 | 37 | 90 | 10 |
| 31 May 16 | 321 | 37 | 87 | 10 |
| 29 Feb 16 | 310 | 36 | 84 | 10 |
| 30 Nov 15 | 301 | 35 | 81 | 10 |
| 31 Aug 15 | 290 | 34 | 79 | 10 |
| 31 May 15 | 283 | 34 | 77 | 10 |
| 28 Feb 15 | 272 | 32 | 75 | 9 |
| 30 Nov 14 | 265 | 31 | 75 | 9 |
| 31 Aug 14 | 256 | 29 | 73 | 9 |
| 31 May 14 | 247 | 28 | 71 | 8 |
| 28 Feb 14 | 236 | 28 | 68 | 8 |
| 30 Nov 13 | 225 | 28 | 65 | 8 |
| 31 Aug 13 | 216 | 28 | 63 | 8 |
| 31 May 13 | 208 | 27 | 61 | 8 |
Quality Earnings: NG2 has a large one-off loss of $63.7M impacting its last 12 months of financial results to 29th February, 2024.
Growing Profit Margin: NG2 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NG2's earnings have declined by 37.7% per year over the past 5 years.
Accelerating Growth: NG2 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: NG2 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).
Return on Equity
High ROE: NG2's Return on Equity (0.05%) is considered low.